MannKind Corp
MNKD
#5739
Rank
HK$9.70 B
Marketcap
HK$30.18
Share price
-2.53%
Change (1 day)
-22.49%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -HK$1.02

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -HK$1.02. In 2025 the company made an earnings per share (EPS) of HK$0.16 a decrease over its 2024 EPS that were of HK$0.78.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.02-749.42%
2025HK$0.16-80%
2024HK$0.78
2022-HK$2.666.25%
2021-HK$2.5128%
2020-HK$1.96-7.41%
2019-HK$2.12
2017-HK$8.70-188.1%
2016HK$9.88-128.31%
2015-HK$34.8874.51%
2014-HK$19.99-20.31%
2013-HK$25.08-32.63%
2012-HK$37.23-28.03%
2011-HK$51.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$30.93-3,135.27%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$242.13-23,862.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-863.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.59-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-HK$52.52 5,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA